Pharmaceutical Intermediates Market Size By Product and By End User 2019-2027| Analysis by Credence Research

The global pharmaceutical intermediates market is anticipated to touch US$ 36,890.6 Mn by 2027, growing at a CAGR of 4.0% from 2019 to 2027.

SANJOSE, United States – July 10, 2019 /MarketersMedia/ —

The latest market report published by Credence Research, Inc. “Global Pharmaceutical Intermediates Market – Growth, Future Prospects, Competitive Analysis, 2019- 2027,” the global pharmaceutical intermediates market was valued at US$ 25,965.0 Mn in 2018, and is expected to reach US$ 36,890.6 Mn by 2027, expanding at a CAGR of 4.0% from 2019 to 2027.

Market Insights:
Pharmaceutical intermediates are manufactured by chemical processing of synthetic and natural resources which finds diverse application in life science industries. Incessant rise in patient population actively seeking medication and flourishing pharmaceutical & biotechnology companies throughout the globe together drive the pharmaceutical intermediates market growth.

Bulk drug intermediates are spearheading the product segment for pharmaceutical intermediates market. Significant rise in drug formulation research & development (FR&D) activities provide the necessary impetus for its market growth. They are used as raw material or as a secondary product generated during the synthesis of active pharmaceutical ingredient (API) having the potential to be used in various drug formulation. Custom intermediates are gaining huge traction owing to the increased drug development and research activities.

Pharmaceutical & biotechnology companies are leading the end user segment for pharmaceutical intermediates market. The major factors contributing towards its excellent market growth are rising prevalence of life-threatening diseases and stringent regulatory norms pertaining to cGMP and cGLP of drug manufacturing sanctioned by healthcare agencies worldwide. In the last 2 decades research laboratories highlighted good market growth owing to the increasing demand of pharmaceutical intermediates in developing novel medicines for the treatment of rare and autoimmune diseases. Contract manufacturing organization will be growing at a rapid pace on account of significant rise in drug manufacturing outsourcing activities to penetrate untapped market throughout the globe.

Get Sample: https://www.credenceresearch.com/sample-request/59749

North America with a market share of 35.8% is dominating the regional segment for pharmaceutical intermediates market. The major factors propelling its market growth are rising public health awareness and the presence of well-developed healthcare infrastructure. Europe is trailing North America in the regional market representing a market share of 30.4% market share on account of increasing patient population seeking medical intervention for life-threatening diseases and supportive regulatory environment provided by European Medical Agency (EMA). The Asia Pacific is holding 20.2% market share owing to proactive government policies favoring flourishing growth of pharmaceutical and biotechnology companies and lucrative market opportunity for key vendors to enter into strategic agreement and collaboration with regional players for manufacturing of generic drugs in the Asia Pacific region.

Companies producing pharmaceutical intermediates are:
*BASF SE,
*Bristol Myers Squibb Company,
*Cambrex Corporation,
*Chiracon GmbH,
*Codexis, Inc.,
*Dishman Group,
*Dextra Laboratories, Ltd.,
*Lonza,
*Midas Pharma GmbH
*Vertellus Holdings LLC

Key Market Movements:

Rising prevalence of life-threatening diseases
The supportive regulatory environment provided by global healthcare agencies
Significant rise in drug formulation research & development (FR&D) activities and the expiration of blockbuster drug patent to provide the necessary impetus for generic drug production

ToC:
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
…………

Chapter 3. Pharmaceutical Intermediates Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global Pharmaceutical Intermediates Market, by Key Players, 2018

Chapter 4. Global Pharmaceutical Intermediates Market, by Product
4.1. Overview
4.2. Bulk Drug Intermediates
4.3. Chemical Intermediates
4.4. Custom Intermediates

Chapter 5. Global Pharmaceutcials Intermediates Market, by End User
5.1. Pharmaceutical & Biotechnology Companies
5.2. Contract Manufacturing Organization
5.3. Research Laboratories

Chapter 6. Global Pharmaceutical Intermediates Market, by Geography
………….

Chapter 7. Company Profiles
7.1. BASF SE
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Bristol Myers Squibb Company
7.3. Cambrex Corporation
7.4. Chiracon GmbH
7.5. Codexis, Inc.
7.6. Dishman Group
7.7. Dextra Laboratories, Ltd.
7.8. Lonza
7.9. Midas Pharma GmbH
7.10. Vertellus Holdings LLC
………………..toc continued

Browse the full report Pharmaceutical Intermediates Market – Growth, Future Prospects, Competitive Analysis, 2019 – 2027

About Us
Credence Research is a worldwide market research and counselling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared for this task.

Popular Reports on Credence Research:

Paget’s disease treatment market is projected to grow at a CAGR of 3.4% during the forecast period from 2019 to 2027

The paroxysmal nocturnal hemoglobinuria (PNH) is currently valued at US$ 2,341.4 Mn in 2018 and is set to reach US$ 6,203.0 Mn by 2027

Medium: Pharmaceutical Intermediates Market: Europe is trailing North America in the regional market representing a market share of 30.4%

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com/report/pharmaceutical-intermediates-market

Source URL: https://marketersmedia.com/pharmaceutical-intermediates-market-size-by-product-and-by-end-user-2019-2027-analysis-by-credence-research/88894736

Source: MarketersMedia

Release ID: 88894736